Objectives: To explore the clinical performance of a strategy of revascularization by
percutaneous coronary intervention (PCI) with drug‐eluting stent (DES) in diabetic patients …

Background Controversy persists regarding the optimal revascularization strategy for
diabetic patients with multivessel coronary artery disease (MVD). Coronary artery bypass …

BACKGROUND: This retrospective study of prospectively collected data compared coronary
artery bypass graft (CABG) surgery to drug‐eluting stenting (DES) in diabetic patients with …

Background Studies comparing coronary artery bypass grafting (CABG) with drug‐eluting
stent (DES) for the treatment of diabetic patients with multivessel disease are relatively …

Abstract Background: The FREEDOM (Future Revascularization Evaluation in Patients with
Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for …

Background Diabetes mellitus is associated with more complex coronary artery diseases.
Coronary artery bypass grafting (CABG) is a preferred revascularization strategy over …

Diabetes is prevalent in patients with coronary artery disease. In diabetic patients with multi-
vessel coronary disease, percutaneous coronary intervention (PCI) and coronary artery …

Background Our aims were to compare coronary artery bypass grafting (CABG) and stenting
for the treatment of diabetic patients with multivessel coronary disease enrolled in the …

Objectives The aim of the Bypass Angioplasty Revascularization in Type 1 and Type 2
Diabetes study was to assess percutaneous coronary intervention (PCI) and coronary artery …

Background: It is unknown if coronary artery bypass grafting (CABG) or percutaneous
coronary intervention (PCI) may offer a survival benefit in patients with type 1 diabetes (T1D) …